Clinical Trial Update: Celecoxib in Preventing Lung Cancer in Former Heavy Smokers [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating celecoxib for preventing lung cancer in former heavy smokers, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED